Analyst initiations: BEC, BT and MITI

Posted May 29th 2008 11:16AM by Eric Buscemi
Filed under: Yahoo! (YHOO), Analyst Initiations

MOST NOTEWORTHY: Beckman Coulter, BT Group and Micromet were today's noteworthy initiations:

Oppenheimer believes Beckman Coulter (NYSE:BEC) is well-positioned to leverage its broad installed base in the clinical lab market to increase sales of its consumable and a new molecular diagnostics instrument expected in 2010. The firm initiated shares with an Outperform rating and $80 target.
Societe Generale expects BT Group's (NYSE:BT) domestic revenues to deteriorate as line erosion accelerates; shares were assumed with a Sell rating.
Roth Capital started Micromet (NASDAQ:MITI) with a Buy rating and $3 target. The firm expects the company's proprietary 'BiTE' antibody platform to gain validation as its lead candidate MT103 starts accumulating clinical data in multiple hematology indications.

OTHER INITIATIONS:

Yahoo! (NASDAQ:YHOO) was initiated with a Neutral rating at Merrill.
Piper resumed coverage of Alexion Pharma (NASDAQ:ALXN) with a Buy rating and $88 target.
MedAssets (NASDAQ:MDAS) was started at Jefferies with a Buy rating and $25 target.

Tags: ALXV, analyst initiations, AnalystInitiations, BEC, BT, MDAS, MITI, YHOO